Adults (18+) with overweight or obesity (BMI \>25 kg/m2)
Not currently taking an incretin-based medication at baseline
Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
Fluent in English
You may not be if
Adults (18+) without overweight or obesity
\<18 years of age at time of testing
Adults not taking a GLP-1 Medication
Adults taking a compound GLP-1
Adults on GLP-1 medication for longer than 2 weeks at baseline
Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
Not fluent in English
Clareo Health | Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
